Myelodysplasia and Naxos disease: a novel pathogenetic association?
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TO THE EDITOR
The myelodysplastic syndromes (MDS) are a heterogeneous group of blood neoplasms characterized by ineffective hemopoiesis and peripheral cytopenia, involving one or more of the non-lymphoid hemopoietic lineages and an increased tendency for evolution into acute leukemia. Although MDS are more often diagnosed in the elderly, clinically, morphologically and biologically similar diseases are also recognized in children. However, because of their lower incidence and clinical variability in the younger patient and the frequent overlap between the myelodysplastic and myeloproliferative syndromes, there is still considerable controversy on the most appropriate classification and optimal therapeutic approach for childhood MDS.
During childhood, MDS frequently arise from inherited constitutional genetic disorders regarded as a background predisposing to the acquisition of genomic lesions or the appearance of other forms of hemopoietic dysfunction. At least 30% of them affect patients with pre-existing inherited genetic disorders, mainly immunodeficiency states, constitutional chromosomal syndromes, DNA repair deficiency conditions and congenital cytopenias. 1 Since the etiologic basis of myelodysplasia remains elusive, the study of such cases is expected to provide additional insight into the cascade of alterations leading to the dysplastic marrow failure.
We describe here two siblings with myelodysplastic syndrome and Naxos disease (ND). ND is an inherited disorder characterized by specific cardiac and cutaneous manifestations resulting from a genetically determined deficiency of plakoglobin, an essential protein component of intercellular junction. This constituent protein is involved in cell adherence and desmosomal junctions, thus having adhesive and signaling functions. 2 Although the cardinal symptoms of ND relate to the derangement of adhesive function, there is increasing evidence that plakoglobin is also involved in several other biological processes, including apoptosis 3 and tumor suppression. 4 We report, for the first time, an association between MDS and ND and discuss the possibility of a pathogenetic link between these two conditions. Case 1 was a 4.-year-old girl referred to our Department because of anorexia, fatigue and pallor during the last month, preceded only by one episode of a few days' fever. Her previous medical history . Repeated (three samples) bone marrow aspiration and biopsy showed a hypercellular marrow with erythroid and megakaryocytic dysplasia (micromegakaryocytes), mild increase of stroma reticular fibers and 15% myeloblasts expressing CD34, CD33 and CD117 on flow cytometry. Cytogenetic analysis on three consecutive bone marrow samples showed normal karyotype (46XX). On the basis of these findings, the diagnosis of refractory anemia with excess of blasts (MDS-RAEB) was established. Bone marrow transplantation was considered and her only brother was called in as a possible donor. Case 2 was case No. 1's brother, a 13-year-old boy who on clinical examination presented with the characteristics of ND, ie woolly hair and a more extensive palmoplantar keratoderma. He had a history of a syncopal episode at the age of 12, and on clinical examination severe ventricular arrhythmia was evident. His electrocardiographic, echocardiographic and angiographic findings were compatible with arrhythmogenic right ventricular cardiomyopathy (ARVC), and the diagnosis was confirmed with endomyocardial biopsy. His arrhythmia was controlled with amiodarone. His hematological investigation revealed neutropenia (1400/l) and moderate macrocytosis. More specifically, peripheral blood tests showed: Hb 13.3 g/dl, Ht 42.1%, MCV 98 fl, MCH 31 pg, MCHC 31.6 g/dl, reticulocytes 1.8%, hemoglobin F 0.7%, WBC 4200/l with 32% hypogranulated polymorphonuclear neutrophils, 62% lymphocytes, 1% eosinophils, 5% monocytes and platelet count 298 000/l.
Apart from an episode of pneumonia at the age of 2 years, there was no history of other major infections. During that episode of pneumonia he had an adequate neutrophilic response (WBC 12 300/l with 70% neutrophils) while a blood count at the age of 4 was normal.
On two consecutive aspirations, the bone marrow was hypercellular with erythroid hyperplasia, a left shift of the granulocytic lineage, 5% myeloblasts and marked trilineage dysplasia, more prominent in the erythroid (multinuclearity, 'megaloblastoid' changes, cytoplasmic bridges) and the megakaryocytic lineage (micromegakaryocytes, dyskaryorrhexis, decreased ploidy). The trephine biopsy showed a relatively decreased cellularity adjusted to the patient's age (F:C = 30:70), mild increase of reticular fibers and trilineage dysplasia. Abnormal localization of immature precursors (ALIP) was also observed. Cytogenetic analysis on two consecutive samples showed a normal karyotype (46XY).
On the basis of these findings the boy was diagnosed as MDS of the refractory cytopenia-type (RC) with multilineage dysplasia and was therefore rejected as a marrow donor, regardless of his HLA identity with his sister. He has been followed, and eighteen months later he remains neutropenic (neutrophils 1300/l). His bone marrow aspirate is still hypercellular with trilineage dysplasia. Moreover, the marrow biopsy shows an increase of fibrosis occupying approximately 50% of the specimen area, alternating areas of hypo-and hypercellularity, ALIP and degenerative alterations of the stroma (ie, demonstrating oedema thus congestion and vascular lesions). Cytogenetic analyses have repeatedly shown a normal karyotype.
DNA analysis of blood samples from both siblings showed that they were homozygous for the molecular lesion characteristic of ND, ie a two-base (TG) deletion in the plakoglobin gene (PK2157del2).
Case 1 was transplanted with an HLA-matched unrelated male cord blood graft. She received busulfan, cyclophosphamide and melphalan as conditioning regimen. On hematological recovery, peripheral blood and bone marrow were normal. A grade III GVHD, mainly involving the intestine, persisted for 6 months and was controlled with anti-thymocyte globulin, steroids and cyclosporine A. Fourteen months later, anemia and thrombocytopenia recurred and the marrow examination showed 66% myeloblasts (CD34 ND is an autosomal recessive disorder characterized by the triad of palmoplantar keratoderma, woolly hair and ARVC leading to arrhythmias, heart failure and sudden death. 2 The disease was first described by Protonotarios et al in families originating from the Greek island of Naxos. Subsequently, it was identified on other Aegean islands. The genetic locus of ND was mapped on the chromosomal region 17q21, and a homozygous two-base (TG) deletion in the plakoglobin gene was later recognized as the responsible genetic defect. 2 Plakoglobin (␥-catenin) is a protein with both adhesive and signaling functions and an important component of junctional complexes in various tissues, including the heart and skin. It is involved in cell-to-cell adhesion and stabilization of actin filaments. Inhibition of plakoglobin expression in cultured human endothelial cells by microinjection of antisense oligonucleotides results in cell-to-cell dissociation in response to shear stress. Plakoglobin is believed to be essential for maintaining cardiomyocyte integrity. Its lack leads to cell detachment and death, followed by fibrofatty repair of the myocardium. 2 It is known that plakoglobin is expressed in certain cultured leukemia cell lines, 5 but its precise role in hemopoiesis remains unexplored. Nevertheless, the transmembrane adhesion molecules of the integrin and cadherin family connect to the cytoskeleton through submembrane proteins, including the catenins. 6 The integrity of these cytoplasmic intermediates appears crucial for proper adhesive function. Presently, the role of cell-to-cell contact in the regulation of hemopoiesis has been given particular significance, and its disruption is considered, at least partly, responsible for the bone marrow failure and the defective differentiation of hemopoietic precursors characterizing MDS.
Another consequence of cell detachment is apoptotic cell death. Recent experimental data indicate that plakoglobin may be directly involved in the inhibition of apoptosis. It was found that high levels of plakoglobin expression in human SSC 9 plakoglobin-deficient cells lead to uncontrolled growth and foci formation. 3 This effect was associated with induction of BCL-2, a prototypic member of apoptosis regulators, and correlated with decreased proteolytic processing and insufficient activation of caspase-3, an important executor of programmed cell death. Accelerated apoptosis of hemopoietic progenitors eventually leading to clonal expansion is a characteristic feature of MDS.
More importantly, there is evidence that plakoglobin itself may act as a tumor suppressor. 4 In gynecological cancers the plakoglobin gene is subjected to loss of heterozygosity, and at least one point mutation has been recognized in the coding sequence. 7 Moreover, plakoglobin is functionally associated with the protein product of APC, another tumor suppressor gene. 6 Overexpression of plakoglobin in SV-40 transformed cells suppresses their tumorigenic potential, and the pattern of its intracellular distribution indicates that this effect is not entirely dependent on the junctional function. 4 These observations may also be of clinical relevance. In certain tumors, a diminished plakoglobin expression correlates with a more invasive phenotype and has been found to represent an independent adverse prognostic factor. 8 Thus plakoglobin deficiency or dysfunction may predispose to the development of MDS since a decreased tumor suppressing activity may facilitate the acquisition of genetic lesions, while accelerated apoptosis and the possibly disturbed intercellular adhesion in the marrow may contribute to the establishment of dysplastic alterations once the neoplastic clone has emerged. The lack of any previous reports of MDS in patients with ND may be explained by the relative rarity of these diseases, the confinement of ND within a rather limited geographic area and the fact that many ND patients die at an early age because of cardiac complications.
We therefore hypothesize that ND may favor the appearance of MDS via possible involvement of plakoglobin deficiency in the pathogenetic process leading to dyshemopoiesis, through derangement of adhesive function in the bone marrow microenvironment, increased apoptosis of hemopoietic precursors and relative lack of protection against the establishment of additional genetic lesions. This assumption, however, requires further basic and clinical investigation, including the elucidation of plakoglobin function in normal and malignant hemopoiesis and a thorough hematological assessment of patients with ND. TO THE EDITOR Cytogenetic analysis of B-precursor ALL at presentation and subsequent relapse frequently reveals subclonal evolution and increasing karyotypic complexity. The emergence of an entirely independent cytogenetically abnormal clone at relapse compared with presentation, however, is an extremely rare event in both paediatric and adult ALL. 1 In fact, a proportion of those rare cases show the emergence of 11q23 abnormalities, and presumed MLL gene rearrangement, during disease progression which, in non-infant cases, is more likely to represent DNA-topoisomerase II inhibitor-induced secondary leukaemia rather than relapse of the primary disease. 1 Minor alterations in immunophenotype are a relatively more common feature of this malignancy, although only 10% of cases exhibit intra-lineage shifts between presentation and relapse. 2 We report the unusual case of a B-precursor ALL exhibiting both an intra-lineage shift and a complete change in cytogenetic karyotype between diagnosis and relapse. A 12-year-old girl presented with lethargy, shortness of breath, weight loss and pallor. Investigations revealed a white cell count (WCC) of 58.9 × 10 9 /l, haemaglobin (Hb) at 2.6 g/dl and platelets at 70 × 10 9 /l, with numerous blast cells on the peripheral blood smear. A marrow aspirate confirmed the diagnosis of acute lymphoblastic leukaemia (FAB type L1). Immunophenotyping of the diagnostic bone marrow sample showed a pre-B ALL phenotype that was surface positive for CD19, CD22, CD24, HLA-DR, CD45 and weakly positive for CD5; surface negative for CD10, CD79b, CD34, CD13 and CD33; cytoplasmic positive and nuclear TdT negative. Analysis of G-banded chromosomes from diagnosis identified eight metaphase cells with a pseudo-diploid karyotype of 46,XX,add(2)(q3?),del(6)(q1?),add(9)(p?2) and two cells exhibiting an apparently normal female karyotype. Additional interphase and metaphase FISH analyses were performed (Leukaemia Research Fund ALL Database Laboratory, Royal Free Hospital, London, UK) and showed no evidence of a TEL/AML1 or MLL gene rearrangement at diagnosis. Furthermore, the presence of a cytogenetically cryptic BCR/ABL rearrangement was excluded by RT-PCR. The patient was treated according to the Medical Research Council (MRC) ALL97 high risk protocol and was randomised to receive prednisolone, cranial radiotherapy and 6-mercaptopurine.
Nineteen months later, during maintenance chemotherapy, relapse of the leukaemia was diagnosed. Immunophenotyping revealed a more immature pro-B cell phenotype of the blast cells that were surface positive for CD19, CD22, HLA-DR and CD5 but surface negative for CD45, CD10, CD34, CD13 and CD33; cytoplasmic CD79a positive; cytoplasmic negative and nuclear TdT positive. Fifty percent of the blasts at relapse were positive for CD15. Interestingly, chromosome analysis identified nine cells with a high-hyperdiploid karyotype of 56,XX,+6,inv(13)(q14q34),+inv(13)(q14q34),+14,+16,+18,+20, +20,+21,+21,+22 In an effort to establish a clonal relationship between the leukaemic populations from diagnosis and relapse, PCR analysis of the IgH gene rearrangements was performed. Amplification of the IgH CDRIII region from tumour cDNA and DNA using Fr3A/J1H consensus primers revealed the presence of the same clonal VDJ H gene rearrangement both at diagnosis and relapse (Table 1 ). In addition, PCR amplification of the TCR␦ gene region from the same material identified the presence of two different clonal TCR␦ rearrangements, TCR V␦2-D␦3 (d) and TCR V␦2-D␦3 (r), at diagnosis and relapse, respectively (Table 1) . Interestingly, the clonal IgH rearrangement common to both the diagnostic and relapse clones did not contain non-template 'N' nucleotides inserted at the D-J H join (Table 1) . This is a common feature of rearrangements generated during foetal development due to the low expression of the enzyme TdT 3 and suggests that the clonal proliferation originated in utero. Similarly, despite the more mature pre-B cell immunophenotype of the presenting tumour population, the diagnostic TCR␦ gene rearrangement, TCR V␦2-D␦3 (d), resembled an immature recombination with virtually no junctional diversity (Table  1) . In contrast, the relapse TCR␦ rearrangement, TCR V␦2-D␦3 (r), exhibited extensive non-template nucleotide insertion typically associated with adult VDJ rearrangements, suggesting temporal differences between the two clonal populations (Table 1) .
Taken together, the presenting and relapsing populations in this leukaemia represent the same clonal disease characterised by a common IgH rearrangement where extensive clonal diversity resulted in the occurrence of a completely independent karyotype and an intra-lineage shift in immunophenotype. Combining the cytogenetic, immunophenotypic and immune system gene rearrangement analyses (Figure 1) , it appeared that the leukaemia arose from a fully IgHrearranged B-precursor, most likely during an early stage of foetal development characterised by low TdT activity.
